Navigation Links
PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice
Date:6/3/2009

Adenosine Regulation with GP531 Improves the Heart's Pumping Function in Dogs with Advanced Chronic Heart Failure

NEW YORK, June 3 /PRNewswire/ -- PeriCor Therapeutics, Inc. announced today that positive preclinical results of its novel cardioprotective agent, GP531, were reported in a poster presentation by Hani N. Sabbah, Ph.D., at the European Heart Failure Congress 2009 in Nice, France. The study was funded by PeriCor Therapeutics, Inc. and conducted by Dr. Sabbah and colleagues at the Division of Cardiovascular Medicine of the Henry Ford Health System, Detroit, Michigan. GP531 is an investigational drug under development by PeriCor Therapeutics under an Investigational New Drug (IND) application.

The study entitled "Intravenous GP531, an Adenosine Regulating Agent, Improves Left Ventricular Function in Dogs with Chronic Advanced Heart Failure" found that an acute intravenous infusion of GP531 at doses ranging from 3 mcg/kg/min to 300 mcg/kg/min significantly improves left ventricular (LV) systolic function. GP531 treatment, as compared to placebo, increased ejection fraction and decreased LV end-diastolic pressure, end-diastolic volume and end-systolic volume. This improvement in the heart's pumping ability was achieved without increasing heart rate or lowering blood pressure, and GP531 did not elicit de-novo ventricular arrhythmias, even at the highest doses.

GP531 is a second generation member of a novel new class of cardioprotective compounds known as adenosine regulating agents (ARAs). ARAs, including GP531, have demonstrated impressive cardioprotective activity in preclinical models of ischemia/reperfusion injury, but this pilot study is the first to evaluate an ARA in a model of heart failure. Dr. Sabbah stated, "This encouraging preclinical study strongly supports continued preclinical and clinical exploration of GP531 as an adjunct therapy for the treatment of acute heart failure syndromes. GP531
'/>"/>

SOURCE PeriCor Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. PeriCor Therapeutics Appoints K. Tucker Andersen to Board of Directors
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
7. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
8. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
9. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
10. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
11. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
(Date:1/15/2014)... 2014 More than 5 million Americans ... in 3 seniors will die with Alzheimer’s or another ... figures have shocked many Americans into looking for ways ... these tragic age-related cognitive disorders. Jonathan Weisman, president of ...
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... ... Its EPA-approved technologies will be widely highlighted during the 6th international conference on "Remediation ... ... May 1, 2010 -- The Adventus Group, a remediation biotechnology enterprise for ...
... ... improving the lives of others through their support of arts and culture, healthcare, education and ... ... and his wife Michele B. Chan will be presented with the 10th KCET ...
... , BEDFORD, Mass. , April 30 MicroCHIPS, Inc., ... a 2010 Edison Best New Product Award™ for its Illume™ product. The ... benefit that it will bring to millions of people with diabetes who ... , , ...
Cached Biology Technology:ADVENTUS Bioremediation Technologies Highlighted at Battelle Symposium. 2ADVENTUS Bioremediation Technologies Highlighted at Battelle Symposium. 3ADVENTUS Bioremediation Technologies Highlighted at Battelle Symposium. 4Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 2Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 3Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 4Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 5MicroCHIPS Honored With 2010 Edison Best New Product Award 2
(Date:4/21/2014)... are growing studies concerning the use of ... of nerve growth factor in neuroscience research. ... and team from Tongji Medical College, Huazhong ... amino-functionalized ethylenediamine-treated multi-walled carbon nanotubes were used ... by non-covalent grafting. Results showed that amino ...
(Date:4/20/2014)... of germsgerms that help to kick-start the infant,s ... infection, may paradoxically interrupt a newborn,s own immune ... dangerous pathogens. , A new animal study ... Philadelphia (CHOP) sheds light on immunology in newborns ... role in fostering the rapid production of infection-fighting ...
(Date:4/18/2014)... a world population predicted to reach 9 billion ... conservation that considers human-altered landscapes such as farmland, ... natural habitat that supports it might be an ... least three-quarters of the land surface is directly ... to human-caused impacts such as climate change. But ...
Breaking Biology News(10 mins):Study of gut microbes, antibiotics: Clues to improving immunity in premature infants 2Stanford researchers rethink 'natural' habitat for wildlife 2Stanford researchers rethink 'natural' habitat for wildlife 3Stanford researchers rethink 'natural' habitat for wildlife 4
... millipedes previously unknown in Australia has been discovered by ... of the widespread tropical family Pyrgodesmidae have been found among ... are not only widespread in Australia,s tropical and subtropical ... been published in the open access journal ZooKeys ...
... Trust and the Engineering and Physical Sciences Research Council ... initiative to find biomedical engineering solutions to challenging healthcare ... provide funding for a limited number of ground-breaking long-term ... are inadequate. Up to 10m over seven years is ...
... 29, 2012 The Crop Science Society of America (CSSA) ... during their Annual Meetings, Oct. 21-24, 2012 in Cincinnati, OH. ... professional achievements and meritorious service. Only 0.3 percent of the ... 2012 class of CSSA Fellows are: Marc C. ...
Cached Biology News:Millipede family added to Australian fauna 2£30 million boost for biomedical engineering research 2Crop Science Society of America presents 2012 class of fellows 2Crop Science Society of America presents 2012 class of fellows 3
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... the blending of thermostable DNA polymerases with ... Template PCR Systems, now introduces the Expand ... product of a family of next-generation PCR ... DNA Polymerase with a novel proofreading protein ...
... Source: Escherichia coli RY 13 5'G AATTC3' ... for 15 min or ethanol precipitation. Storage Conditions: ... 1.0mM DTT, 0.15% Triton X-100, 0.01% BSA, 50% ... Store at -20C. Unit Definition: One unit is ...
Biology Products: